Exercise-induced asthma: diagnosis and management (Q34880512)

5 August 2017

1 reference

title

Exercise-induced asthma: diagnosis and management (English)

1 reference

5 August 2017

1 reference

Ricardo A Tan

1

1 reference

5 August 2017

Sheldon L Spector

series ordinal

2

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Annals of Allergy, Asthma & Immunology

5 August 2017

published in

1 reference

5 August 2017

volume

89

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

226-35; quiz 235-7, 297

1 reference

Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Asthma in United States olympic athletes who participated in the 1998 olympic winter games

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Prevalence of exercise-induced airway narrowing in schoolchildren from a Mediterranean town

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise response in 404 young men with asthma: no evidence for a late asthmatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Keeping children with exercise-induced asthma active

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The mechanism of exercise-induced asthma is ...

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Respiratory water loss as a stimulus to exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise-induced asthma: is it the right diagnosis in elite athletes?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Prevalence and characteristics of late asthmatic responses to exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise-induced asthma: is there space for late-phase reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise-Induced Asthma and the Athlete

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Comparison of bronchoconstriction induced by cycling and running

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The exercise bronchoprovocation test: Standardization of procedures and evaluation of response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Eucapnic voluntary hyperventilation as a bronchoprovocation technique: development of a standarized dosing schedule in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Improvement after training of children with exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Effect of physical training on exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Effect of aerobic training on forced expiratory airflow in exercising asthmatic humans

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Dietary salt restriction improves pulmonary function in exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise-induced bronchospasm in high school athletes via a free running test: incidence and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The incidence of exercise-induced bronchospasm in competitive figure skaters.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Exercise-induced asthma in figure skaters

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The effect of prolonged submaximal warm-up exercise on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Nocturnal asthma and exercise-induced bronchospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Protective effects of repeated short sprints in exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Effect of long-term salmeterol treatment on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Time course of the protective effect of inhaled heparin on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Inhaled frusemide and exercise-induced bronchoconstriction in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961948-5

7 January 2021

10.1016/S1081-1206(10)61948-5

Identifiers

DOI

1 reference

5 August 2017

1 reference